Laboratorios Saval S.A. has acquired a pharmeceutical processing plant
Laboratorios Saval S.A. has acquired a pharmeceutical processing plant in Costa Rica from Laboratorios Stein S.A.
Laboratorios Saval is a Chilean company with more than 80 years of history. It began its history in Spain in the 1930s and today, has a presence in more than 14 countries. The company manufactures and distributes pharmaceuticals in the areas of infectious diseases, ophthalmology, immunology and oncology, gastroenterology, bronchopulmonary, cardiology, psychiatry and rheumatology.
Laboratorios Stein is a leading company in Latin America in the commercialization and distribution of highly complex pharmaceutical products including innovative products, biosimilars and complex generics.
Oaklins’ team in Chile acted as financial advisor to Laboratorios Saval in this transaction.
Sprechen Sie mit dem Deal Team
Transaktionen
Cerbios-Pharma wurde von HAS Healthcare Advanced Synthesis übernommen.
Cerbios-Pharma S.A. wurde von HAS Healthcare Advanced Synthesis S.A. übernommen. Gemeinsam bilden sie eine weltweit führende CDMO-Gruppe mit komplementären Stärken in Entwicklung, Produktion und regulatorischer Unterstützung chemischer und biologischer Wirkstoffe. Die neue Gruppe vereint technologische Exzellenz mit umfassendem Know-how für die Anforderungen des globalen Pharmamarkts.
Mehr erfahrenPharma-Skan & Skan-Medic have been acquired by Brygge Partners
Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.
Mehr erfahrenThe Canton of Solothurn had a valuation report prepared for its hospitals
The Canton of Solothurn is the owner of Solothurner Spitäler AG (soH), with its three hospitals in Solothurn, Olten and Dornach.
Mehr erfahren